Back
Boston Properties 10K Form
Sell
38
BXP
Boston Properties
Last Price:
58.70
Seasonality Move:
1.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-02-27 | 10K | BXP/Boston Properties Annual |
2023-11-07 | 10Q | BXP/Boston Properties Quarterly |
2023-08-07 | 10Q | BXP/Boston Properties Quarterly |
2023-05-03 | 10Q | BXP/Boston Properties Quarterly |
2023-02-27 | 10K | BXP/Boston Properties Annual |
2022-11-04 | 10Q | BXP/Boston Properties Quarterly |
Receive BXP News And Ratings
See the #1 stock for the next 7 days that we like better than BXP
BXP Financial Statistics
Sales & Book Value
Annual Sales: | $3.27B |
---|---|
Cash Flow: | $387.15M |
Price / Cash Flow: | 7.08 |
Annual Sales: | $37.45 |
Price / Book: | 1.57 |
Profitability
EPS (TTM): | 1.21000 |
---|---|
Net Income (TTM): | $190.29M |
Gross Margin: | $2.06B |
Return on Equity: | 2.31% |
Return on Assets: | 0.76% |
Boston Properties Earnings Forecast
Key Boston Properties Financial Ratios
- The Gross Profit Margin over the past 27 years for BXP is 62.85%.
- The Selling, General & Administrative Expenses for BXP have been equal to 5.74% of Gross Profit Margin.
- The Research & Development expenses have been 1.83% of Revenue.
- The Interest Expense is 304.69% of Operating Income.
- The Net Earning history of BXP is 5.81% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 16 years.
Boston Properties Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Office REITs |
Sector: | Real Estate |
Current Symbol: | BXP |
CUSIP: | 101121 |
Website: | bxp.com |
Debt
Debt-to-Equity Ratio: | 2.7 |
---|---|
Current Ratio: | 4.19 |
Quick Ratio: | 4.08 |
Price-to-Earnings
Trailing P/E Ratio: | 48.5 |
---|---|
Forward P/E Ratio: | 26.59 |
BXP Technical Analysis vs Fundamental Analysis
Sell
38
Boston Properties (BXP)
is a Sell
Is Boston Properties a Buy or a Sell?
-
Boston Properties stock is rated a Sell
The current Boston Properties [BXP] share price is $58.69. The Score for BXP is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.